Aster DM Healthcare receives CCI approval for QCIL transaction
Aster DM Healthcare (BSE:ASTERDM) announced that it has received approval from the Competition Commission of India (“CCI”) for its proposed transaction involving Quality Care India Limited (“QCIL”). The transaction includes the acquisition of 190,46,028 equity shares of QCIL, held by BCP Asia II TopCo IV Pte. Ltd and Centella Mauritius Holdings Limited, for a consideration other than cash. The consideration will be the issuance and allotment of 186,07,969 equity shares of Aster DM Healthcare, with a face value of INR 10 each, on a preferential basis to the QCIL shareholders ("Share Swap"). The transaction also encompasses a scheme of amalgamation between Aster DM Healthcare and QCIL. The CCI's approval, dated April 15, 2025, allows the company to proceed with the proposed transaction, and the detailed order from the CCI is pending.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Aster DM Healthcare publishes news
Free account required • Unsubscribe anytime